Your browser doesn't support javascript.
loading
Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease.
Faria, Maria João; González-Méijome, José M; Real Oliveira, M Elisabete C D; Carracedo, Gonzalo; Lúcio, Marlene.
Affiliation
  • Faria MJ; Centre of Physics of Minho and Porto Universities (CF-UM-UP), Universidade do Minho, Campus de Gualtar, Braga 4710-057, Portugal. Electronic address: id9658@alunos.uminho.pt.
  • González-Méijome JM; Centre of Physics of Minho and Porto Universities (CF-UM-UP), Universidade do Minho, Campus de Gualtar, Braga 4710-057, Portugal; CEORLab - Clinical and Experimental Optometry Research Lab, Centre of Physics, Universidade do Minho, Campus de Gualtar, Braga 4710-057, Portugal. Electronic address: jgm
  • Real Oliveira MECD; Centre of Physics of Minho and Porto Universities (CF-UM-UP), Universidade do Minho, Campus de Gualtar, Braga 4710-057, Portugal. Electronic address: beta@fisica.uminho.pt.
  • Carracedo G; Department of Optometry and Vision, Faculty of Optics and Optometry, University Complutense of Madrid, C/Arcos de Jalon 118, Madrid 28037, Spain. Electronic address: jgcarrac@ucm.es.
  • Lúcio M; Centre of Physics of Minho and Porto Universities (CF-UM-UP), Universidade do Minho, Campus de Gualtar, Braga 4710-057, Portugal; CBMA - Centre of Molecular and Environmental Biology, Department of Biology, Universidade do Minho, Campus de Gualtar, Braga 4710-057, Portugal. Electronic address: mluci
Adv Drug Deliv Rev ; 210: 115321, 2024 07.
Article in En | MEDLINE | ID: mdl-38679293
ABSTRACT
Posterior eye disorders, such as age-related macular degeneration, diabetic retinopathy, and glaucoma, have a significant impact on human quality of life and are the primary cause of age-related retinal diseases among adults. There is a pressing need for innovative topical approaches to treat posterior eye disorders, as current methods often rely on invasive procedures with inherent risks. Limited success was attained in the realm of topical ophthalmic delivery through non-invasive means. Additionally, there exists a dearth of literature that delves into the potential of this approach for drug delivery and theranostic purposes, or that offers comprehensive design strategies for nanocarrier developers to surmount the significant physiological ocular barriers. This review offers a thorough and up-to-date state-of-the-art overview of 40 studies on therapeutic loaded nanocarriers and theranostic devices that, to the best of our knowledge, represent all successful works that reached posterior eye segments through a topical non-invasive administration. Most importantly, based on the successful literature studies, this review provides a comprehensive summary of the potential design strategies that can be implemented during nanocarrier development to overcome each ocular barrier.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / Theranostic Nanomedicine Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev / Adv. drug deliv. rev / Advanced drug delivery reviews Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / Theranostic Nanomedicine Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev / Adv. drug deliv. rev / Advanced drug delivery reviews Year: 2024 Document type: Article